News Express

Science News: Physical Medicine and Rehabilitation and Interdisciplinary Spine Clinic Referrals Are Associated With Increased Conversion to Spine Surgery

December 03, 2025

Currently, in the US, many patients receive immediate referral to a spine surgeon upon concern for any spine pathology prior to undergoing conservative management. However, research has demonstrated that referrals to spine surgeons for common problems such as low back pain are often not indicated. This leads to inefficient care, delayed conservative treatments, and longer wait times for available surgical consultations. This study highlights an opportunity to improve efficiency in care for patients and clinicians through proper triaging for spine surgery.

Science News: Safety and Efficacy of Apitegromab in Nonambulatory Type 2 or Type 3 Spinal Muscular Atrophy (SAPPHIRE): A Phase 3, Double-Blind, Randomised, Placebo-Controlled Trial

November 18, 2025

This article summarizing the results of the SAPHPHIRE trial, a double blind, placebo-controlled, phase 3 clinical trial on the safety and efficacy of apitegromab (myostatin inhibitor) in patients with spinal muscular atrophy (SMA) type 2 and 3.

Science News: Nerve Conduction Studies in Guillain–Barré Syndrome

November 03, 2025

Science News: Dry Needling in Those With Fibromyalgia

October 15, 2025

Science News: Early Nerve Testing Yields Key Insights in Acute Guillain–Barré Syndrome Diagnosis

October 07, 2025

Electrophysiologic changes in early Guillain-Barré syndrome can be nondiagnostic. Improved testing paradigms may improve hyperacute treatment.

Science News: Utility of Bilateral Biopsy for Amyloid Detection During Carpal Tunnel Release

September 18, 2025

Science News: Targeted Exercise Program Shows Promising Benefits for Aging Adults

September 04, 2025

Science News: Study Exposes Gaps in Nerve Pain Treatments

August 21, 2025

Science News: Prolonged Intubation as an Alternative to Tracheostomy and GT Placement

August 08, 2025

Science News: Prolonged Intubation as an Alternative to Tracheostomy and GT Placement

Science News: Early Promise for ANX005 as a Targeted Therapy in Guillain-Barré Syndrome

July 28, 2025

Early Promise is shown for ANX005 as a Targeted Therapy in Guillain-Barré Syndrome.

Science News: Platelet-Poor Plasma for Muscle Injuries

July 16, 2025

Science News: Clinical Trial Finds Telitacicept Reduces MG Symptoms Within Weeks

June 26, 2025

Clinical Trial Finds Telitacicept Reduces MG Symptoms Within Weeks

Science News: A Better Way to Move: Evaluating Assistive Devices for Easier Ambulation

June 16, 2025

Injuries to the knee, lower leg, ankle, and foot accounted for nearly 17% of all emergency department visits in 2017. Researchers explored if using a hands-free crutch (HFC) displays potential for easier completion of ADLs and reduction in energy requirements.

Science News: Limited Benefit of TFSNRIs in Spinal Stenosis

May 28, 2025

This study is a retrospective analysis of multiple outcome measures evaluated by patient survey looking at the benefit of TFSNI in patients with spinal stenosis and radicular pain

Science News: Thymectomy Trends in MG After MGTX Trial

May 16, 2025

Thymectomy for Myasthenia Gravis: Utilization Trends and Disparities After the MGTX Trial.

Science News: Eculizumab in Severe Guillain‐Barré Syndrome

May 05, 2025

This review discusses the results of eculizumab in cases of severe Guillain-Barré syndrome.

Science News: Improving Muscle Grade Accuracy With EMG

April 17, 2025

This review discusses a study that supports the reliability of MMT in assessment of key muscles in spinal cord injury patients.

Science News: Initial Clinical Experience and Outcomes of Ravulizumab in AChR+ gMG

April 03, 2025

Analyzing a study that evaluates the initial clinical experience of using ravulizumab, a long-acting C5 monoclonal antibody, in patients with acetylcholine receptor antibody-positive generalized myasthenia gravis (AChR+ gMG).

Science News: Long-Term Efficacy and Safety of Apitegromab in Nonambulatory SMA Patients

March 20, 2025

This study examines the long-term efficacy and safety of apitegromab (SRK-015) in nonambulatory patients with SMA over 36 months, showing sustained motor function improvements and a favorable safety profile.

Science News: Serial Nerve Conduction Studies in Guillain-Barré Syndrome: Its Usefulness and Precise Timing

March 11, 2025

This multicenter retrospective study aimed to assess the usefulness of serial nerve conduction studies in patients with Guillain-Barré syndrome who undergo nerve conduction studies at an early stage.